# High-Dose Esterified Estrogens in Treating Postmenopausal Women With Metastatic Breast Cancer That Has Failed Previous Hormone Therapy

> **NCT00131924** · PHASE2 · TERMINATED · sponsor: **Northwestern University** · enrollment: 1 (actual)

## Conditions studied

- Breast Cancer

## Interventions

- **BIOLOGICAL:** esterified estrogens

## Key facts

- **NCT ID:** NCT00131924
- **Lead sponsor:** Northwestern University
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2004-03
- **Primary completion:** 2006-01
- **Final completion:** 2006-01
- **Target enrollment:** 1 (ACTUAL)
- **Why stopped:** Data Monitoring Committee recommended closure due to poor accrual.
- **Last updated:** 2012-06-11

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00131924

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00131924, "High-Dose Esterified Estrogens in Treating Postmenopausal Women With Metastatic Breast Cancer That Has Failed Previous Hormone Therapy". Retrieved via AI Analytics 2026-06-12 from https://api.ai-analytics.org/clinical/NCT00131924. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*